Cipla signs licensing pact with MultiG for COVID-19 rapid antibody test kit
'Covi-G' has been commercialised in 20+ countries, with sensitivity and specificity exceeding 92 per cent, informs company
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.